SOX2 haploinsufficiency promotes impaired vision at advanced age
Metrics: PDF 217 views | HTML 336 views | ?
Leire Moreno-Cugnon1, Ander Anasagasti2, Maitane Ezquerra-Inchausti2, Ander Izeta3, Pedro de la Villa4,5, Javier Ruiz-Ederra2,5 and Ander Matheu1,6
1Cellular Oncology Group, Biodonostia Health Research Institute, San Sebastián, Spain
2Sensorial Neurodegeneration Group, Biodonostia Health Research Institute, San Sebastián, Spain
3Tissue Engineering Laboratory, Biodonostia Health Research Institute, San Sebastián, Spain
4Visual Neurophysiology, IRYCIS, University of Alcala, Madrid, Spain
5RETICS OFTARED, Madrid, Spain
6IKERBASQUE, Basque Foundation for Science and CIBERfes, Bilbao, Spain
Ander Matheu, email: firstname.lastname@example.org
Javier Ruiz-Ederra, email: email@example.com
Keywords: Sox2; haploinsufficiency; aging; retina stem cell progenitors; vision loss
Received: July 18, 2018 Accepted: November 01, 2018 Published: November 30, 2018
Age-related vision loss has been associated with degeneration of the retina and decline in Müller glia cell activity. Sox2 is a critical transcription factor for the development and maintenance of the mammalian retina. Here we determined the role of Sox2 in retinal aging. We observed a decline in the number of Sox2-positive Müller, amacrine and ganglion cells with age. We also explored the impact of Sox2 haploinsufficiency (Sox2GFP) on the activity of Müller glia cells and vision loss with age. Reduction of Sox2-positive cells promoted impaired Müller glia cell function at advanced age of Sox2GFP. These findings correlated with a significant decline in electroretinographic response in Sox2 haploinsufficient mice. Together, these results indicate that Sox2 is required for the maintenance of the transmission of visual information from cones and rods, and suggest that decline in Sox2 expression is responsible for retinal cell aging and age-related vision loss.
Visual deterioration occurs in healthy individuals with age, with impairment in acuity, contrast sensitivity, visual field and dark adaptation, among other changes, which have a dramatic effect on the quality of life in older people . As individuals age, all mammalian ocular tissues undergo various anatomical changes. The internal membrane of the retina becomes thicker and neural elements with gliosis are decreased in the periphery of the retina . Furthermore, aging induces a reduction in the nuclei in the outer nuclear layer of the retina. There is an age-related loss of rods in the macula, which leads to a decrease in scotopic sensitivity . To function properly, the retinal overall size and the proportion of each retinal cell type must be strictly regulated. Among the seven retinal cell types, all derived from a pool of multipotent retinal progenitor cells (RPCs), Müller glia (MG) is the principal macroglia of the retina and maintain stem cell characteristics, including the expression of RPC markers . With age, there is a decline in the number of retinal ganglion cells (RGCs) and interneurons, which comprise amacrine, bipolar and horizontal cells . Moreover, deregulation of MG may be the primary mechanism for age-related retinal degeneration . To date, the molecular mechanisms responsible for age-related vision loss remain largely unknown.
Sox2 (Sry-box containing gene 2) is a key factor in maintaining and inducing the pluripotency of embryonic cells. Moreover, it is highly expressed in stem cells both in embryonic and adult stages, and plays a critical role in the neural central system, including neural retina [6, 7]. In the retina, Sox2 is expressed in RPCs and its strict regulation is a critical factor for RPC differentiation during development . Moreover, the expression of Sox2 is restricted to neural retinal cells  and it is required for the maintenance of quiescence at early postnatal MG [10–12]. Studies in mouse models of Sox2 have shown that conditional ablation of this factor compromises the proliferation and differentiation capacities of RPCs, while hypomorphic levels cause an aberrant differentiation that leads to diverse microphthalmic phenotypes in postnatal animals . The deficiency of Sox2 in MG is associated with disruption of amacrine and horizontal cell neurites in the nuclear and outer plexiform layers, respectively, suggesting a role for Sox2 in the maintenance of retinal cytoarchitecture and function . These results translate to human pathologies, with 10% of individuals with anophthalmia or severe microphthalmia having haploid insufficiency due to SOX2 mutations .
Previous evidence supports the idea that Sox2 levels regulate RPC identity and differentiation in a dose-dependent way, but little is known about its effect on the retina with age. Thus, in this study, we explored the effects of Sox2 haploinsufficiency in aged retina.
Aged Sox2-haploinsufficient mice have fewer numbers of certain retinal cell types
Given the role of MG in supporting retinal neurons, and that alterations in this cell type give rise to the disruption of axons and dendrites , we first determined the expression of Sox2 in MG, amacrine and ganglion cells (RGCs) in young wt and Sox2GFP mice. In young animals, Sox2 haploinsufficient mice had similar numbers of Sox2-positive MG and amacrine cells compared to wt mice, but fewer RGCs (Figure 1A, 1B).
Figure 1: Young Sox2-haploinsufficient mice have normal numbers of retinal cells. (A) Representative immunostaining of Sox2 in the retina of young wt and Sox2GFP mice. (B) Relative quantification of Sox2-positive staining in Müller, amacrine and ganglion cells in young (1–2 month-old) Sox2GFP relative to wt mice. ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer. Statistical differences (*p < 0.001) were assessed between genotypes by Student’s t test. n = 3 mice, 6 retinas/group.
Next, we conducted the same analysis in over 21-month-old Sox2GFP and wt mice. Importantly, the relative numbers of MG, amacrine cells and RGCs positive for Sox2 were 0.86, 0.76 and 0.59 respectively, in aged Sox2GFP normalized to the numbers in aged wt mice (Figure 2A, 2B). When we compared mice of different ages, we detected smaller number of Sox2-positive cells among the different retinal cell types in aged mice of both phenotypes, Sox2GFP and wt, than in young mice (Figure 2C). However, the difference was more marked in Sox2-haploinsufficient mice, with the detection of fewer Sox2 positive cells corresponding to MG, amacrine cells and RGCs in aged Sox2GFP mice than in wt mice (Figure 2C). These results indicate that there is a significant decline in the number of Sox2-positive cells in different cell layers of the retina with age, which is aggravated in Sox2 haploinsufficient mice.
Figure 2: Aged Sox2-haploinsufficient mice have small numbers of certain retinal cell types. (A) Representative immunostaining of Sox2 in the retina of aged (over 24 month-old) wt and Sox2GFP mice. (B) Relative quantification of Sox2 positive staining in Müller, amacrine and ganglion cells in aged (over 24-month-old) Sox2GFP compared to wt mice. (C) Quantification of the number of Sox2-positive cells in retinal cell types in wt and Sox2GFP mice at different ages. Statistical differences (*p < 0.05, **p < 0.01) were assessed between genotypes by Student’s t test. n = 3 mice, 6 retinas/group.
Sox2 haploinsufficient mice have impaired visual function at advanced age
To assess changes in MG morphology and function, retinas from young (1–2 month-old) and aged (over 21-month-old) Sox2GFP and wt mice were stained with Cellular retinaldehyde-binding protein (CRALBP). The resulting images revealed that the structure of MG and intensity of staining was similar in young mice (Figure 3A, 3B). However, MG structure is less organized in Sox2GFP than wt mice. Moreover, there was less intensity in CRALBP staining in aged Sox2GFP than in wt mice (Figure 3C, 3D), features that might indicate an alteration in MG function in aged Sox2 haploinsufficient mice.
Figure 3: CRALBP expression is reduced in aged Sox2-haploinsufficient mice. (A, B) Representative immunostaining (left) and relative intensity of CRALBP in young Sox2GFP compared to wt mice. (C, D) Representative immunostaining (left) and relative intensity of CRALBP in aged Sox2GFP compared to wt mice. Statistical differences (**p < 0.01) were assessed between genotypes by Student’s t test. n = 3 mice, 6 retinas/group.
To determine the effect of Sox2 haploinsufficiency on visual function, we evaluated retinal physiology in wt and Sox2GFP mice by recording electroretinographic (ERG) responses. Figure 4 shows the scotopic (i.e., rod photoreceptors activity in dark-adapted mice) and photopic (i.e., cone photoreceptors activity in light-adapted mice) ERG responses induced by different light intensities in mice of both Sox2GFP and wt genotypes at advanced age. Sox2GFP mice showed weaker ERG responses than wt mice to light intensities of –2 log cd·s/m2 and 1.5 log cd·s/m2 recorded in dark-adapted conditions. Mean data on rod-driven scotopic threshold response (STR) showed significant differences between genotypes, with response amplitudes of 111.29 μV in wt and 56.28 μV in Sox2GFP mice (Figure 4A, 4B). Similarly, when the mixed responses of cones and rods were compared (indicated on the graph as scotopic-b, mixed-a and mixed-b), the amplitudes of response were smaller in haploinsufficient than wt mice (Figure 4C, 4D). We also assessed the ERG responses of aged wt and Sox2GFP mice under photopic conditions. The ERG b-wave (a reflection of ON bipolar and Müller cell activity) was found to be smaller in Sox2GFP than in wt mice (Figure 4E). Moreover, we detected smaller amplitude in the oscillatory potential (OP), which refelcts amacrine cell activity; and in the response of rods and rod-associated cells in Sox2GFP mice (132.30 μV vs 205.19 μV in wt mice; Figure 4F). Taken together, our results show aberrant signal transmission from cone photoreceptors to cone bipolar cells in mice with Sox2 haploinsufficiency, a condition that is associated with aging. Moreover, Sox2GFP mice dispalyed an impaired vision at advanced age.
Figure 4: Aged Sox2-haploinsufficient mice have impaired visual function. (A) Scotopic electroretinographic (ERG) (rod-driven) response elicited by a –2 log cd∙s∙m–2 flash stimulus in wt and Sox2GFP mice of around 1 year of age, recorded in left and right eyes (n = 3). (B) Histogram representation of scotopic threshold response (STR) and scotopic b-wave amplitudes. (C) Mixed ERG (rod plus cone) responses elicited by a 1.5 log cd∙s∙m–2 stimulus under scotopic conditions. (D) Cone responses elicited by a 1.5 log cd∙s∙m–2 stimulus under photopic conditions. (E) Histogram representation of mixed a- and b-wave amplitudes (F) Histogram representation of OP and cone b-wave responses under photopic conditions. Statistical differences (*p < 0.05, **p < 0.01) were assessed between genotypes by Student’s t test.
In this study, we show the essential role for Sox2 in the age-associated decline in retinal cell function and visual activity. During vertebrate eye development, the expression of Sox2 must be strictly regulated at all major stages of retinal development . Moreover, this transcription factor strictly regulates the choice between maintenance of retinal progenitor cell identity and differentiation . In the adult retina, MG constitute the principal cell type for the maintenance of retinal homeostasis  and their loss has been reported to be associated with retinal degeneration with age . In this work, we revealed a decline in Sox2 expression in MG with age and showed this decrease impairs the activity of these cells. These results indicate that SOX2 might play a critical role in the maintenance of retinal stem cells with aging. In line with a putative role of Sox2 in stem cell aging, it has been recently reported that Sox2 expression decreases with age in neurogenic human and mouse brain samples , where Sox2 is a well-established stem cell maker of neural stem cells, and it plays a critical role in the maintenance of their identity [7, 15–17]. Moreover genetically modified mice that show delayed neural stem cell exhaustion, impaired neurogenesis and increased lifespan, have higher levels of Sox2 expression in the neurogenic niches .
Our results uncover a novel role for Sox2 in driving the age-associated deregulation and depletion of MG, extending the critical role of Sox2 in regulating MG at postnatal stage. Thus, Sox2 ablation in MG resulted in postnatally retinal disorganization and degeneration [20–23]. Further, we have observed an age-associated decline in Sox2 expression in amacrine and ganglion cells. These results provide additional evidence of the impact of Sox2 in aged-associated retinal cell dysfunction. As in the case of MG, Sox2 is expressed in amacrine cells, where its activity is required for postnatal immature amacrine cell function and Sox2 deletion leads to aberrant development [3, 24]. We have also detected a reduction in the number of Sox2 ganglion cells in Sox2GFP mice retina, consistent with previous studies where low levels of Sox2 have been associated with the loss of retinal ganglion cells . In line with this, astrocytic loss of Sox2 affects the vascular architecture in maturity . Together, our results demonstrate the essential role of this factor for the maintenance of cellular homeostasis in the retina with age.
Our data show a reduction in ERG b-wave amplitudes under scotopic and photopic conditions in aged Sox2GFP mice, suggesting impaired signal transmission from cones to bipolar cells. We also found that aged Sox2GFP mice have impaired visual function, indicating the critical role that Sox2 plays in age-related vision maintenance. Prior to our work, ablation of Sox2 during postnatal retinal maturation in MG had been shown to give rise to structural abnormalities of the retina associated with a decrease in b-wave amplitude, which has been linked to its origin in MG . Moreover, Sox2 ablation postnatally was found to result in a significant decrease in ERG a- and b-wave amplitudes at 1 month of age . While these studies demonstrated the need for Sox2 for the maintenance of retinal function, our study determined the role of this transcription factor under the chronic effects of physiological aging. Our work highlights that precise regulation of Sox2 expression is critical for temporal and spatial regulation of several types of retinal cells, including retinal progenitor cells, and thereby retinal function. In line with this, there is a dose-dependent effect of Sox2 on retinal progenitor competence . The relevance of these results is reinforced by the severe eye malformations present in patients with SOX2 mutations [26, 27].
In summary, our work demonstrates the critical role for Sox2 in retinal function and age-related vision loss, activities that might provide an explanation for understanding how hypomorphic levels of Sox2 expression result in retinal defects in humans. Indeed, there is a hypothesis that proposes Sox2 levels as predictor of disease in the retina . This theory supports the idea that once the levels of SOX2 decreases up to phenotypic levels (threshold established in 40% of normal) disorders may start to develop . Our results indicate that there might be a correlation between the severity of the phenotype and the levels of SOX2 expression, not only in disease but also during physiological aging.
MATERIALS AND METHODS
B6;129S-Sox2tm2Hoch/J mice, from now on Sox2GFP , were housed in a pathogen-free barrier facility at the Biodonostia Health Research Institute and handled in compliance with the regulations on animal research specified in the European Union Directive [2010/63/EU]. All experiments were approved by the Biodonostia Institute and University of Alcala animal care, research and experimentation ethic committees. Mice were used for the study without considering the gender of the animals.
Eyes from young (1–2 month-old) and aged (over 21-month old) mice were dissected and fixed in paraformaldehyde (PFA, 158127-5006, Sigma-Aldrich) for 24 h, and then stored in sucrose (Panreac) 10% for 2 h, 20% for 2 h and 30% for 1 week, before embedding them in OCT. A total of 6 retinas from 3 mice were analyzed per age and genotype. Serial sections of 7 μm were cut using a CM1950 Cryostat (Leica). An average of 15 sagittal sections/eye were obtained from central retina. Retinal sections were incubated with SOX2 (1:500, Neuromics) or CRALBP (1:500, abcam), overnight at 4°C. Secondary antibodies were incubated for 1 h at room temperature (1:1000, Thermo Fisher), together with 4′,6-diamidno-2-phenylindole (DAPI) to stain the nuclei. Retinal sections were then mounted with Fluoro-Gel (Electron Microscopy Sciences). Cell immunofluorescence was evaluated with an Eclipse 80i microscope and processed with NIS-Elements Advanced Research software (both from Nikon). Images from the entire retinal section were captured so that the total number of each retinal cells type was analyzed in each section. The total number of nuclei was determined using the DAPI channel. CRALBP intensity was evaluated using Image J Software.
ERG measurements were made in 10- to 12-month-old mice, by an observer blind to the experimental condition of the animals. Mice were dark-adapted (>12 h) and deeply anesthetized with an intraperitoneal injection of saline solution (NaCl 0.9%) containing ketamine (125 mg/kg; Imalgene; Merial, Pirbright, England) and xylazine (5 mg/kg; Xilagesic; Calier, Granollers, Barcelona, Spain). During the entire procedure, animals were handled under indirect dim red light (>620 nm) and their body temperature was kept at 37°C on a heating platform (Hot-Cold, Pelton Shepherd Industries, Stockton, CA). Before recording, the pupils of the mice were dilated by applying topically two drops of 1% tropicamide (Culircusi Tropicamida; Alcon Cusí S.A., El Masnou, Barcelona, Spain). ERG responses were recorded using four electrodes: left and right corneal electrodes (contact lens type) (Burian-Allen, Hansen Ophthalmic Development Lab, Coralville, IA) centered on the visual axis 0.5 mm from the cornea, a reference electrode placed in the mouth, and a ground electrode attached to the tail. To optimize electrical recording and to prevent corneal surface desiccation, a topical drop of 2% methyl-cellulose (Methocel, Ciba Vision, Hetlingen, Switzerland) was administered to each eye immediately before placing the corneal electrode.
Electroretinographic responses to light stimuli were recorded using a full-field electroretinography technique. Low-intensity (<−2 log Cd·s/m2) stimuli were applied in a Ganzfeld dome, which ensures homogeneous illumination of at least the central 120° of the retina, whereas for higher-intensity stimuli (>−2 log Cd·s/m2), a single light-emitting diode was placed close to each eye. The electrophysiological response recorded was amplified and filtered (CP511 AC amplifier; Grass Instruments, Quincy, MA), and then digitalized (ADInstruments Ltd, Oxfordshire, UK). The whole process was controlled with Scope version 3.8.1 software (Power Lab, ADInstruments Ltd). The dim scotopic response (DSR), and rod (scotopic-b), mixed (a- and b-wave), and oscillatory potential (OP) responses were recorded sequentially under dark background conditions, and cone (photopic-b) and flicker responses were recorded following 5 minutes of light adaptation with background white light (50 Cd/m2).
All data were expressed as the mean ± standard error of the mean (SEM). Student’s t test was used to assess differences between two groups in normally distributed data. All analyses were performed using GraphPad Prism 5 Software, version 5.01 (Graph Pad Software).
L.M-C. AA and M.E-I performed, and analyzed most of the experiments. L.M-C designed experiments and helped to write the manuscript. PV performed and analyzed electrophysiology experiments. AI maintained colony, supervised experiments and critically reviewed the manuscript. AM and J.R-E designed, supervised, wrote the manuscript and obtained funding for the study.
CONFLICTS OF INTEREST
L-MC and AA have received predoctoral fellowships from the Department of the Education, University and Research of the Basque Government. This work was supported by grants from the Carlos III Health Institute and European Regional Development Fund (PI13/02277, CP16/00039, PI16/01580) to AM (PI13-02098; RD16/0008/0020; RD16/0008/0027) to PV (PI13/02621; CPII16/00012; RD16/0008/0027) to JRE and Diputacion Foral Gipuzkoa, and the Departments of Industry and Health of the Basque Government, as well as from the European Union (Marie Curie CIG 2012/712404 and RefbioII) to AM.
1. Kolesnikov AV, Fan J, Crouch RK, Kefalov VJ. Age-related deterioration of rod vision in mice. J Neurosci. 2010; 30:11222–11231.
2. Grossniklaus HE, Nickerson JM, Edelhauser HF, Bergman LA, Berglin L. Anatomic alterations in aging and age-related diseases of the eye. Invest Ophthalmol Vis Sci. 2013; 54:ORSF23–27.
3. Bachleda AR, Pevny LH, Weiss ER. Sox2-Deficient Muller Glia Disrupt the Structural and Functional Maturation of the Mammalian Retina. Invest Ophthalmol Vis Sci. 2016; 57:1488–1499.
4. Samuel MA, Zhang Y, Meister M, Sanes JR. Age-related alterations in neurons of the mouse retina. J Neurosci. 2011; 31:16033–16044.
5. DiLoreto DA Jr, Martzen MR, del Cerro C, Coleman PD, del Cerro M. Muller cell changes precede photoreceptor cell degeneration in the age-related retinal degeneration of the Fischer 344 rat. Brain Res. 1995; 698:1–14.
6. Sarkar A, Hochedlinger K. The sox family of transcription factors: versatile regulators of stem and progenitor cell fate. Cell Stem Cell. 2013; 12:15–30.
7. Ellis P, Fagan BM, Magness ST, Hutton S, Taranova O, Hayashi S, McMahon A, Rao M, Pevny L. SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult. Dev Neurosci. 2004; 26:148–165.
8. Taranova OV, Magness ST, Fagan BM, Wu Y, Surzenko N, Hutton SR, Pevny LH. SOX2 is a dose-dependent regulator of retinal neural progenitor competence. Genes Dev. 2006; 20:1187–1202.
9. Kamachi Y, Uchikawa M, Collignon J, Lovell-Badge R, Kondoh H. Involvement of Sox1, 2 and 3 in the early and subsequent molecular events of lens induction. Development. 1998; 125:2521–2532.
10. Matsushima D, Heavner W, Pevny LH. Combinatorial regulation of optic cup progenitor cell fate by SOX2 and PAX6. Development. 2011; 138:443–454.
11. Karl MO, Hayes S, Nelson BR, Tan K, Buckingham B, Reh TA. Stimulation of neural regeneration in the mouse retina. Proc Natl Acad Sci U S A. 2008; 105:19508–19513.
12. Heavner WE, Andoniadou CL, Pevny LH. Establishment of the neurogenic boundary of the mouse retina requires cooperation of SOX2 and WNT signaling. Neural Dev. 2014; 9:27.
13. Kriegstein A, Alvarez-Buylla A. The glial nature of embryonic and adult neural stem cells. Annu Rev Neurosci. 2009; 32:149–184.
14. Dubois-Dauphin M, Poitry-Yamate C, de Bilbao F, Julliard AK, Jourdan F, Donati G. Early postnatal Muller cell death leads to retinal but not optic nerve degeneration in NSE-Hu-Bcl-2 transgenic mice. Neuroscience. 2000; 95:9–21.
15. Favaro R, Valotta M, Ferri AL, Latorre E, Mariani J, Giachino C, Lancini C, Tosetti V, Ottolenghi S, Taylor V, Nicolis SK. Hippocampal development and neural stem cell maintenance require Sox2-dependent regulation of Shh. Nat Neurosci. 2009; 12:1248–1256.
16. Ferri AL, Cavallaro M, Braida D, Di Cristofano A, Canta A, Vezzani A, Ottolenghi S, Pandolfi PP, Sala M, DeBiasi S, Nicolis SK. Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain. Development. 2004; 131:3805–3819.
17. Pevny LH, Nicolis SK. Sox2 roles in neural stem cells. Int J Biochem Cell Biol. 2010; 42:421–424.
18. Carrasco-Garcia E, Moreno-Cugnon L, Garcia I, Borras C, Revuelta M, Izeta A, Lopez-Lluch G, de Pancorbo MM, Vergara I, Vina J, Matheu A. SOX2 expression diminishes with ageing in several tissues in mice and humans. Mech Ageing Dev. 2018 Mar 21. https://doi.org/10.1016/j.mad.2018.03.008. [Epub ahead of print].
19. Carrasco-Garcia E, Arrizabalaga O, Serrano M, Lovell-Badge R, Matheu A. Increased gene dosage of Ink4/Arf and p53 delays age-associated central nervous system functional decline. Aging Cell. 2015; 14:710–714.
20. Surzenko N, Crowl T, Bachleda A, Langer L, Pevny L. SOX2 maintains the quiescent progenitor cell state of postnatal retinal Muller glia. Development. 2013; 140:1445–1456.
21. Frishman LJ. Chapter 7: Electrogenesis of the Electroretinogram. Retina (5th ed.). 2013; 1:177–201. https://doi.org/10.1016/B978-1-4557-0737-9.00007-2.
22. Li H, Collado M, Villasante A, Matheu A, Lynch CJ, Cañamero H, Rizzoti K, Carneiro C, Martínez G, Vidal A, Lovell-Badge R, Serrano M. p27(Kip1) directly represses Sox2 during embryonic stem cell differentiation. Cell Stem Cell. 2012; 11:845–852.
23. Gorsuch RA, Lahne M, Yarka CE, Petravick ME, Li J, Hyde DR. Sox2 regulates Muller glia reprogramming and proliferation in the regenerating zebrafish retina via Lin28 and Ascl1a. Exp Eye Res. 2017; 161:174–192.
24. Whitney IE, Keeley PW, St John AJ, Kautzman AG, Kay JN, Reese BE. Sox2 regulates cholinergic amacrine cell positioning and dendritic stratification in the retina. J Neurosci. 2014; 34:10109–10121.
25. Kautzman AG, Keeley PW, Nahmou MM, Luna G, Fisher SK, Reese BE. Sox2 regulates astrocytic and vascular development in the retina. Glia. 2018; 66:623–636.
26. Fantes J, Ragge NK, Lynch SA, McGill NI, Collin JR, Howard-Peebles PN, Hayward C, Vivian AJ, Williamson K, van Heyningen V, FitzPatrick DR. Mutations in SOX2 cause anophthalmia. Nat Genet. 2003; 33:461–463.
27. Fitzpatrick DR, van Heyningen V. Developmental eye disorders. Curr Opin Genet Dev. 2005; 15:348–353.
28. Arnold K, Sarkar A, Yram MA, Polo JM, Bronson R, Sengupta S, Seandal M, Geijsen N, Hochedlinger K. Sox2(+) adult stem and progenitor cells are important for tissue regeneration and survival of mice. Cell Stem Cell. 2011; 9:317–329.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.